$SCL

Stepan (NYSE: SCL) VP reports RSU vesting and 50-share tax withholding

Stepan Company's VP and GM Surfactants-INT, Robin Joseph Weitkamp, reported the vesting of 90 Restricted Stock Units (RSUs) on May 11, 2026. To cover tax obligations, 50 shares of common stock, valued at $52.58 each, were withheld. After these transactions, Weitkamp directly holds 40 shares and indirectly holds 96.9 shares through the ESOP II Trust.

Original reporting
Published May 13, 2026, 8:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 13, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SCL
Neutral
medium confidence
Mentioned
$SCL
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$SCLNeutralLow
01

Why it matters

The event is routine and unlikely to influence stock price significantly; it reflects compensation management rather than corporate performance.

02

Market read

The insider activity is routine and has negligible impact on trading strategies.

03

What to watch

This event is routine; overlooking broader market conditions is a risk when overemphasizing insider activity.

Timing: low

Background

Robin Joseph Weitkamp, VP and GM Surfactants-INT at Stepan, reported RSU vesting and stock withholding for tax purposes, a standard compensation event.

Company-level read

Ticker impact

$SCLNeutralMedium confidence
Context

The news pertains to insider stock transactions involving Stepan Company (NYSE: SCL), specifically the vesting of RSUs and stock withholding for tax purposes.

Expected impact

Minimal short-term price movement expected; no significant impact anticipated.

Evidence & confidence

Insider transactions like RSU vesting and stock withholding are common and typically do not influence stock valuation unless accompanied by other material news.

Market effects

Limited; routine insider activity without broader sector impact.

Minimal; no regional effects expected.

Negligible; specific to company insider activity.

Counterpoint

Some traders might interpret insider stock withholding as a sign of confidence in the company's future, potentially supporting the stock.

Key entities

  • Stepan Company

    A manufacturer of specialty chemicals.

  • Robin Joseph Weitkamp

    VP and GM Surfactants-INT at Stepan.

Related articles

$SCLMed

Stepan Company Q2 2026 Earnings Call Summary

Strategic Performance Drivers Adjusted EBITDA growth of 45% was driven by a combination of 6% organic volume growth, disciplined pricing execution, and ramping productivity gains. Surfactant performance benefited from broad-based demand across all end markets, specifically led by industrial cleaning, laundry, and oil field sectors. Margin recovery was achieved through the rigorous application of contractual pass-through mechanisms and pricing actions to offset fluctuating raw material costs.

$SCLMedAI 8/10

Stepan Reports Second Quarter 2026 Results

Stepan (NYSE: SCL) reported Q2 2026 net income of $22.9M, up 102% year over year, and adjusted net income of $27.1M, up 126%. Adjusted EBITDA rose 45% to $74.4M. Net sales increased 15% to $684.1M, with organic volume up 6%. Free cash flow was -$15.0M due to working capital. The company plans to cut about 100 salaried roles under Project Catalyst and expects full-year restructuring charges of $75.0M-$80.0M.

$SCLMed

STEPAN CO (SCL): Results of Operations and Financial Condition

STEPAN CO (SCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d139905dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Stepan Reports Second Quarter 2026 Results Northbrook, Illinois, July 29, 2026 — Stepan Company (NYSE: SCL) today reported: Second Quarter 2026 Highlights • Reported net income was $22.9 million, up 102% versus the prior ye

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

$SCLHighAI 9/10

Daily NZX update, Wednesday, May 27, 2026

The NZX50 rose 0.7% to extend gains to 3.1% over five days and 3.1% for the month (still down 2.0% over six months; up 4.6% YoY). Kathmandu Holdings jumped 14% and KMD reported Q3 FY26 sales +5.2% YoY and gross margin 58.2% (+258 bps). Vista Group gained 4% on a new five-year Cinemex deal; PaySauce revenue rose 3% to $9.2m.

$LMTMed

What is the Patriot missile system and why are supplies depleted worldwide?

Reuters explains the U.S. Patriot mobile air defense system, built by Raytheon Technologies, and its PAC-2 and PAC-3 interceptor variants. Demand has risen as Russia’s strikes in Ukraine and the Middle East conflict have depleted interceptor stocks. CSIS estimates about 65% of U.S. interceptors were used Feb-July, leaving under 850. Lockheed received a contract up to $58.6B.